Pembrolizumab Improves Survival for Some Patients with Advanced Non-Small Cell Lung Cancer

A summary of clinical trial results showing that pembrolizumab improved progression-free and overall survival for patients with advanced non-small cell lung cancer.


Media Type: Html
  • SourceUrl: https://www.cancer.gov/node/1071558/syndication
  • Syndication ID: 16567
  • Language: English
  • Source: National Cancer Institute (NCI)
  • Date Syndication Captured: Tuesday, January 24, 2017 at 10:10 PM
  • Date Syndication Updated: Monday, August 05, 2019 at 07:40 PM
Preview   0 Users liked this content.

Embed Code Snippet


To get the embed code snippet please Login.